Pfizer Inc. (PFE)’s Amy Schulman, named to head one of the company’s three new drug units starting next month, will instead leave the company. Schulman, a deputy to Chief Executive Officer Ian Read and Pfizer’s general counsel, was chosen in July to lead one of the businesses as the New York-based company reorganized ahead of a potential breakup. Albert Bourla, a 20-year Pfizer veteran, will now head the unit, which handles vaccines, oncology and consumer health products, Pfizer said in a statement today.
Help employers find you! Check out all the jobs and post your resume.
